MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerhardt, C. C.
Right arrow Articles by Issad, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerhardt, C. C.
Right arrow Articles by Issad, T.

Vol. 55, Issue 2, 255-262, February 1999

Stimulation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by Human Beta-3 Adrenergic Receptor: New Pharmacological Profile and Mechanism of Activation

C. C. Gerhardt, J. Gros, A. D. Strosberg, and T. Issad

Institut Cochin de Génétique Moléculaire, Centre National de la Recherche Scientifique and Université Paris VII, Laboratoire d'Immuno-Pharmacologie Moléculaire, Paris, France

We present evidence that stimulation of the human beta-3 adrenergic receptor (AR), expressed in Chinese hamster ovary/K1 cells, specifically activates the mitogen-activated protein kinases extracellular signal-regulated kinase (ERK)1 and 2, but not JNK or p38. The extent and kinetics of the ERK stimulation by the beta-3 AR are identical with those of the endogenic insulin receptor. However, insulin augments cellular proliferation, whereas beta-3 AR agonists inhibit proliferation due to the production of cyclic AMP. The pharmacological profile of the ERK activation by the beta-3 AR differs significantly from its activation of adenylyl cyclase. The order of potency and intrinsic activities of both natural ligands, norepinephrine and epinephrine, is inversed between both signaling pathways. In addition, BRL 37344 and propranolol, ligands that act as agonists in the stimulation of cyclase, act as antagonists for ERK activation. The activation of ERK1/2 is sensitive to pertussis toxin, suggesting that the beta-3 AR, in addition to its interaction with Gs, can couple to Gi/o. Furthermore, the activation of ERK by the beta-3 AR is sensitive to PD98059, wortmannin, and LY294002, indicating a crucial role for mitogen-activated protein kinase kinase and phosphatidylinositol-3 kinase (PI3K), respectively. A beta-3 AR-mediated stimulation of PI3K is confirmed by the observation that the selective agonist CGP 12177A specifically activates protein kinase B. As was observed for the activation of ERK, the activation of protein kinase B is inhibited by preincubation with pertussis toxin and PI3K inhibitors, suggesting that both are a consequence of a Gi/o-mediated activation of PI3K.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Sato, D. S. Hutchinson, B. A. Evans, and R. J. Summers

Mol. Pharmacol., November 1, 2008; 74(5): 1417 - 1428.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Sato, T. Horinouchi, D. S. Hutchinson, B. A. Evans, and R. J. Summers
Ligand-Directed Signaling at the beta3-Adrenoceptor Produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) Relative to Receptor Agonists
Mol. Pharmacol., November 1, 2007; 72(5): 1359 - 1368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Robidoux, N. Kumar, K. W. Daniel, F. Moukdar, M. Cyr, A. V. Medvedev, and S. Collins
Maximal beta3-Adrenergic Regulation of Lipolysis Involves Src and Epidermal Growth Factor Receptor-dependent ERK1/2 Activation
J. Biol. Chem., December 8, 2006; 281(49): 37794 - 37802.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. S. Dallner, E. Chernogubova, K. A. Brolinson, and T. Bengtsson
{beta}3-Adrenergic Receptors Stimulate Glucose Uptake in Brown Adipocytes by Two Mechanisms Independently of Glucose Transporter 4 Translocation
Endocrinology, December 1, 2006; 147(12): 5730 - 5739.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Sato, D. S. Hutchinson, T. Bengtsson, A. Floren, U. Langel, T. Horinouchi, B. A. Evans, and R. J. Summers
Functional Domains of the Mouse {beta}3-Adrenoceptor Associated with Differential G Protein Coupling
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1354 - 1361.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. G. Baker
Evidence for a Secondary State of the Human {beta}3-Adrenoceptor
Mol. Pharmacol., December 1, 2005; 68(6): 1645 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. S. L. Chan and Y. H. Wong
Gq-Mediated Activation of c-Jun N-Terminal Kinase by the Gastrin-Releasing Peptide-Preferring Bombesin Receptor Is Inhibited upon Costimulation of the Gs-Coupled Dopamine D1 Receptor in COS-7 Cells
Mol. Pharmacol., November 1, 2005; 68(5): 1354 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Sano, A. R. Leff, S. Myou, E. Boetticher, A. Y. Meliton, J. Learoyd, A. T. Lambertino, N. M. Munoz, and X. Zhu
Regulation of Interleukin-5-Induced {beta}2-Integrin Adhesion of Human Eosinophils by Phosphoinositide 3-Kinase
Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 65 - 70.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. S. Hutchinson, M. Sato, B. A. Evans, A. Christopoulos, and R. J. Summers
Evidence for Pleiotropic Signaling at the Mouse {beta}3-Adrenoceptor Revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol Oxalate]
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1064 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Robay, G. Toumaniantz, V. Leblais, and C. Gauthier
Transfected {beta}3- but Not {beta}2-Adrenergic Receptors Regulate Cystic Fibrosis Transmembrane Conductance Regulator Activity via a New Pathway Involving the Mitogen-Activated Protein Kinases Extracellular Signal-Regulated Kinases
Mol. Pharmacol., March 1, 2005; 67(3): 648 - 654.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Maudsley, L. Davidson, A. J. Pawson, R. Chan, R. L. de Maturana, and R. P. Millar
Gonadotropin-Releasing Hormone (GnRH) Antagonists Promote Proapoptotic Signaling in Peripheral Reproductive Tumor Cells by Activating a G{alpha}i-Coupling State of the Type I GnRH Receptor
Cancer Res., October 15, 2004; 64(20): 7533 - 7544.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Breit, M. Lagace, and M. Bouvier
Hetero-oligomerization between {beta}2- and {beta}3-Adrenergic Receptors Generates a {beta}-Adrenergic Signaling Unit with Distinct Functional Properties
J. Biol. Chem., July 2, 2004; 279(27): 28756 - 28765.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. CANNON and J. NEDERGAARD
Brown Adipose Tissue: Function and Physiological Significance
Physiol Rev, January 1, 2004; 84(1): 277 - 359.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Chernogubova, B. Cannon, and T. Bengtsson
Norepinephrine Increases Glucose Transport in Brown Adipocytes via {beta}3-Adrenoceptors through a cAMP, PKA, and PI3-Kinase-Dependent Pathway Stimulating Conventional and Novel PKCs
Endocrinology, January 1, 2004; 145(1): 269 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Myou, A. R. Leff, S. Myo, E. Boetticher, A. Y. Meliton, A. T. Lambertino, J. Liu, C. Xu, N. M. Munoz, and X. Zhu
Activation of Group IV Cytosolic Phospholipase A2 in Human Eosinophils by Phosphoinositide 3-Kinase Through a Mitogen-Activated Protein Kinase-Independent Pathway
J. Immunol., October 15, 2003; 171(8): 4399 - 4405.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. A. Kohout, H. Takaoka, P. H. McDonald, S. J. Perry, L. Mao, R. J. Lefkowitz, and H. A. Rockman
Augmentation of Cardiac Contractility Mediated by the Human {beta}3-Adrenergic Receptor Overexpressed in the Hearts of Transgenic Mice
Circulation, November 13, 2001; 104(20): 2485 - 2491.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Greney, P. Ronde, C. Magnier, F. Maranca, C. Rascente, W. Quaglia, M. Giannella, M. Pigini, L. Brasili, C. Lugnier, et al.
Coupling of I1 Imidazoline Receptors to the cAMP Pathway: Studies with a Highly Selective Ligand, Benazoline
Mol. Pharmacol., June 1, 2000; 57(6): 1142 - 1151.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. M. Fredriksson, J. M. Lindquist, G. E. Bronnikov, and J. Nedergaard
Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression in Brown Adipocytes through a beta -Adrenoreceptor/cAMP/Protein Kinase A Pathway Involving Src but Independently of Erk1/2
J. Biol. Chem., April 28, 2000; 275(18): 13802 - 13811.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J Gros, C. Gerhardt, and A. Strosberg
Expression of human (beta)3-adrenergic receptor induces adipocyte-like features in CHO/K1 fibroblasts
J. Cell Sci., January 11, 1999; 112(21): 3791 - 3797.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
W. Cao, A. V. Medvedev, K. W. Daniel, and S. Collins
beta -Adrenergic Activation of p38 MAP Kinase in Adipocytes. cAMP INDUCTION OF THE UNCOUPLING PROTEIN 1 (UCP1) GENE REQUIRES p38 MAP KINASE
J. Biol. Chem., July 13, 2001; 276(29): 27077 - 27082.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Communi, N. S. Gonzalez, M. Detheux, S. Brezillon, V. Lannoy, M. Parmentier, and J.-M. Boeynaems
Identification of a Novel Human ADP Receptor Coupled to Gi
J. Biol. Chem., October 26, 2001; 276(44): 41479 - 41485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Lindquist, J. M. Fredriksson, S. Rehnmark, B. Cannon, and J. Nedergaard
beta 3- and alpha 1-Adrenergic Erk1/2 Activation Is Src- but Not Gi-mediated in Brown Adipocytes
J. Biol. Chem., July 21, 2000; 275(30): 22670 - 22677.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics